FDA Approval and Psychedelic Clinical Trials

Janssen Pharmaceuticals Spravato

Janssen Pharmaceuticals received FDA approval for Ketamine as Esketamine in 2019 and it is now being marketed as Spravato.

Ketamine works by:

Interacting with some of the brain’s neurotransmitters. Ketamine can work by relieving anxiety and pain relief and acting as an antidepressant. Using medical supervision, lower doses of ketamine can relax your mind and help you to temporarily disengage from your routine thought patterns. Combining Ketamine therapy with psychotherapy, studies found it can be helpful in reducing anxiety and depression. 

linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram